The strain on clinic and surgeon resources resulting from a rise in demand for total knee replacement (TKR) requires reconsideration of when and how often patients need to be seen for follow-up. Surgeons will otherwise require increased paramedical staff or need to limit the number of TKRs they undertake. We reviewed the outcome data of 16 414 primary TKRs undertaken at our centre to determine the time to re-operation for any reason and for specific failure mechanisms. Peak risk years for failure were determined by comparing the conditional probability of failure, the number of failures divided by the total number of TKRs cases, for each year. The median times to failure for the most common failure mechanisms were 4.9 years (interquartile range (IQR) 1.7 to 10.7) for femoral and tibial loosening, 1.9 years (IQR 0.8 to 3.9) for infection, 3.1 years (IQR 1.6 to 5.5) for tibial collapse and 5.6 years (IQR 3.4 to 9.3) for instability. The median time to failure for all revisions was 3.3 years (IQR 1.2 to 8.5), with an overall revision rate of 1.7% (n = 282). Results from our patient population suggest that patients be seen for follow-up at six months, one year, three years, eight years, 12 years, and every five years thereafter. Patients with higher pain in the early post-operative period or high body mass index (≥ 41 kg/m²) should be monitored more closely.

Cite this article: Bone Joint J 2013;95-B:1484–9.

Source of the study: University of Auckland, Auckland, New Zealand and University of Otago, Christchurch, New Zealand. Outcomes following knee arthroplasty are typically defined as implant survivorship at defined timepoints, or revision incidence over time. These estimates are difficult to conceptualise, and lack context for younger patients with more remaining years of life. We therefore aimed to determine a ‘lifetime’ risk of revision as a more useful metric for total (TKA) and unicompartmental knee arthroplasty (UKA). The New Zealand Joint Registry was used to identify 96,497 primary TKAs and 13,481 primary UKAs performed between 1999 and 2019. Patient mortality and revision incidence were also extracted. Estimates of lifetime risk were calculated using an actuarial lifetable method. The estimates were stratified by age and gender. Reasons for revision were categorised using previously published standardised definitions. The lifetime risk of UKA revision was two-fold higher than TKA across all age groups (range 3.7-40.4% UKA, 1.6-22.4% TKA). Revision risk was higher for males with TKA (range 3.4%-25.2% males, 1.1%-20% females), but higher for females with UKA (range 4.3%-43.4% vs. 2.9%-37.4% for males). Revision due to infections were higher for TKA (1.5% males, 0.7% females) compared with UKA (0.4% males, 0.1% females). The increased risk in younger UKA patients was associated with higher incidence of aseptic loosening (UKA 2%, TKA 1%) and ‘unexplained pain’ (UKA 2%, TKA 0.2%). The risk for UKA was two-fold higher than TKA, and this was partially explained by a higher proportion of revisions due to ‘unexplained pain’. For TKA, males had higher risk of revision, in contrast to UKA where females had higher risk; this gender difference was associated with higher incidence of infections with TKA. Younger age, gender and higher ASA status were also associated with increased lifetime risk of UKA revision. Lifetime risk of revision can provide a meaningful measure of arthroplasty outcomes to aid patient counselling

Seventy-one Geomedic total knee replacements were reviewed retrospectively at a maximum of eight and a half years. The prosthesis was found to be successful in its primary aim of relieving pain. However, there was an overall failure rate of 18.3%. Analysis of the results by an actuarial method allowed comparison with other prostheses. The factors involved in failure are discussed

The risk factors associated with 34 deep infections from a consecutive series of 803 total hip replacements have been analysed using standard actuarial methods. The follow-up ranged from 3 to 10 years. Absence of prophylactic antibiotics, complications after operation, discharging wounds, previous operations and remote infection were related to the development of deep periprosthetic infection. An early discharge from the wound with growth of micro-organisms, though superficial in appearance, proved to be associated with a high risk of developing late deep infection. The mechanisms associated with deep infection involved multiple interrelated risk factors. Multiple regression analysis of our data indicated that these risk factors, when acting together, potentiate their effect on the development of the deep infection

A prospective nation-wide study of knee arthroplasty has been under way in Sweden since October 1975. By the end of 1983, 4505 arthroplasties for osteoarthritis and 3495 for rheumatoid arthritis had been recorded and reviewed one, three and six years after the operation. Using actuarial methods, the probability of the prosthesis remaining in situ after six years was calculated. In osteoarthritis this probability ranged from 65% for hinged prostheses to 90% for medial compartment prostheses. Two-and three-compartment prostheses produced intermediate results with 87% survival. In rheumatoid arthritis the probability varied from 72% for medial compartment prostheses to 90% for two- and three-compartment prostheses. The main reason for failure was loosening of the components, the second most common was infection. The probability of revision for infection by six years was 2% in osteoarthritis and 3% in rheumatoid arthritis. Most revisions were to a three-compartment prosthesis. Knee fusion at primary revision was required in 2% of the cases at six years

The survivorship of total hip replacements in patients operated on at the Royal National Orthopaedic Hospital has been analysed using standard actuarial methods. Between 1963 and 1972 173 metal-on-metal prostheses of various developmental designs were inserted. Between 1969 and 1972 248 prostheses of one design using a metal femoral component and plastic cup were used. The patients were surveyed retrospectively and for each the actual follow-up period was determined as well as the eventual outcome. The criterion of "survival" was that the prosthesis was still in situ and all such prostheses were regarded as "survivors", regardless of whether the patients experienced pain or loss of function. The survivorship was then determined by constructing life tables. The results indicate that for metal-on-metal prostheses the overall probability of survival was only 53 per cent after 11 years and the average annual probability of removal, irrespective of cause, was 5.5 per cent. The results were better for metal-on-plastic prostheses with figures of 88 per cent after eight years and 1.5 per cent respectively. For both prostheses the predominant reason for failure was loosening and the annual rate of removal for loosening increased as the follow-up time increased, suggesting that loosening was a wearing out process. The advantages of the survivorship method of analysis as compared with conventional methods are discussed

Introduction: The purpose of this study was to report on the minimal 10-year followup results of a prospective randomized and a historical series of low friction cemented hip arthroplasties according to the surface finish of the femoral implant. Patients and Methods: The prospective randomized series included 284 patients (310 hips) with a mean age of 64.1 years. Among these 310 hips, the femoral component had a highly polished surface (Ra = 0.04 micron, MKIII, Stryker) in 165 hips, and a matte surface finish (Ra = 1.7 microns, CMK3, Vector Orthopedique) in the remaining 145 hips. The historical series that was operated by the sames surgeons according to the same surgical technique included 111 patients (123 hips) with a satin finish femoral component (Ra = 0.9 micron, CMK2, Sanortho). Clinical results were rated according to the Merle d’Aubigne hip score. Radiologic analysis was performed according to the criteria of Barrack et al. for the definition of loosening. Moreover, a survival analysis according to the actuarial method was conducted. Results: At the minimum 10-year follow-up evaluation, 43 patients (48 hips) were lost to follow-up (0.3 to 8.7 years), 80 patients (83 hips) were deceased (0.1 to 13.6 years), 26 patients had revision of either or both components (0.9 to 15.9 years), and 246 patients (276 hips) were alive and had not been revised after a mean 12.3 ± 1.9 years (10 to 16 years). Radiologic loosening of the femoral component, including revision, occured in one, four, and 15 hips for the polished, stain, and matte groups, respectively. The survival rate at 13 years of the femoral component, using loosening as the end point, was 97.3 ± 2.6% (95% CI, 92.2 to 100%), 97.1 ± 2.1% (95% CI, 93 to 100%), and 78.9 ± 5.8% (95% CI, 67.6 to 90.3%) for polished, satin, and matte stems, respectively. Discussion: This study demonstrated that cement fixation of a femoral component was more reliable in the long term with a polished or satin surface finish. Based upon our results and the review of the literature, we recommend abondoning the use of cemented stems with a surface roughness greater than 1 micron

Purpose: The purpose of this retrospective study was to evaluate the clinical and radiological results of Charnley-Keroboull total hip arthroplasty performed in patients aged less than 50 years. We searched for factors which might affect wear and sustained fixation. Material and methods: Among the 2,804 arthroplasties performed in patients aged less than 50 years between 1975 and 1995, we selected randomly 287 (10% of the annual operations). These prostheses were implanted in 222 patients (144 women and 78 men), mean age 40.1±8 years (15–50). All of the arthroplasties were inserted via a transtrochanteric approach. Charnley-Kerboull implants were cemented in all patients using a metal polyethylene bearing. Functional outcome was assessed with the Postel-Merle-d’Aubigné score. Cup wear was measured with the Chevrot technique. The actuarial method was used to calculate prosthesis survival. Results: At last follow-up, 155 patients (210 hips) were living and had not had a revision procedure at mean 16.1±4.6 years, 23 patients (25 hips) required revision of the acetabular or femoral element, ten patients (10 hips) had died, and 34 patients (42 hips) were lost to follow-up. The mean preoperative functional score was 9.6±2.5 (9–15) versus 17.2±0.8 (9–18) at last follow-up (Wilcoxon rank test p< 0.001). For the acetabular element, there was certain loosening in 15 hips and possible loosening in 24. For the femoral element, loosening was certain for 12 implants and possible for four. Twentyfive hips required revision, including 17 for aseptic loosening. Mean wear was 0.12±0.21 mm (0–2.23). Among the 287 hips, 196 had wear measured at less than 0.1 mm/yr (mean 0.02 mm/yr). Mean overall implant survival, defining revision as failure, was 85.4±5.0% at twenty years (95%CI 78.4–92.4). Among the factors tested, only abnormally rapid wear (> 0.1 mm/yr) was predictive of failure. Discussion: The results of this series allow us to conclude that total hip arthroplasty using a Charnley-Kerboull implant remains the best solution for young patients in terms of implant survival

Purpose: Among 115 cemented patellofemoral Bechtol-Blazina prostheses implanted between 1974 and 1991, we reviewed 59 knees in 41 women and nine men (nine bilateral implants). Material and methods: Mean patient age was 60 years and mean follow-up was ten years (6–16). The main indication was primary degenerative disease (82%) followed by chondrocalcinosis (6%), chondromalacia (7%) and secondary degeneration (5%). A previous procedure had been performed on 18 knees (14 patellofemoral and four femorotibial). Associated procedures were tubercle translocation (n=15), tibial osteotomy (n=2), and tension of the medial wing (n=1). The International Knee Society score was noted. Results: According to the IKS, outcome was good or excellent in 91% of the knees and insufficient in 9% (knee score and function score). Mean ten-year survival determined with the actuarial method was 84.4%. It fell from 91.1% to 75.5% between the ninth and eleventh year due to femorotibial deterioration. There were no cases of phlebitis, infection or prosthetic loosening. Causes of failure were predominantly femorotibial (eight degradations) rather than femoropatellar (two snaps and three painful syndromes involving the lateral parapatellar area). Thirteen reoperations were necessary: tri-compartmental arthroplasty (n=8), modification of the trochlear orientation (n=1), release of the lateral patellar wing (n=3), demaquetisation (n=1). Total or nearly total pain relief was achieved for 80% of the knees. The mean flexion angle was 123° and stair climbing was considered normal in 91% of the patients. All knees were stable. Radiographically, there were six cases of polyethylene remodelling and one case of wear associated with major femorotibial deterioration. This absence of significant wear was, in our opinion, essentially due to the absence of a metal-backed patellar insert. Discussion: The following indications can be retained on the basis of this series: the ideal indication is isolated patellofemoral osteoarthritis with dysplasia, relative indications are advanced-stage patellofemoral osteoarthritis with axial deviation having no clinical or radiographic (tangent view) impact. In this case, the patellofemoral implant allows postponing insertion of a tricompartmental prosthesis in middle-aged patients. Contraindications are patellar chondromalacia, chondrocalcinosis, low patella, and presence of associated femorotibial degradation. Conclusion: The long-term clinical and radiographic results after patellofemoral arthroplasty make this procedure the treatment of choice for isolated and advanced-stage patellofemoral osteoarthritis on a normally axed limb when a conservative procedure cannot be performed or has failed. It provides effective pain relief and good knee stability. The operation is difficult and must use congruent implants to avoid the problem of prosthetic instability and patellar snaps

The topic of this study was to research the survival rate of ATLAS hip prosthesis (acetabular cup) performed by one operating surgeon only and with a minimum of 10 years follow up. Material and method: The ATLAS cup was hemispheric, in titanium alloy TA6V4, with a thin layer (2.5mm). It had a large central orifice as well as a radial slot allowing a certain elasticity enabling a pressfit impaction. Between January 1989 and December 1995, 297 ATLAS were implanted in the Clinique Saint André of Reims, 171 ATLAS II non hydroxyapatite coated and 126 ATLAS III hydroxyapatite coated. There were 176 women (59,2%) and 121 men (40,8%). The average age was 66 (20 to 94). Each patient was contacted by phone to find out if the prosthesis was still in place or whether a new operation had been performed. For the deceased patients, the family or the usual doctor were contacted by phone to answer the question with a maximum of details. The non-parametric survival rates were performed using the actuarial method according to Kaplan-Meier. The results were given with a reliability rate of 95%. The PRISM program was used. RESULTS: On the 1st of January 2006, out of the 297 patients present at the start, 38 patients (12,8%) could not be contacted, 70 patients (23,5%) had died, 35 were reviewed and 120 answered the phone inquiry. 32 patients had undergone a revision: 23 due to the cup: there were 15 cases of wear of the polyethylene, 4 osteolysis, 3 cases of recurring dislocation and a secondary tilt of the cup, 5 cases of acetabular and femoral revision for 4 femoral loosening (change of cup by principal) and 4 cases of revision of the femoral components only. The survival rate of the global series of 297 ATLAS (coated and non coated with hydroxyapatite) taking into consideration only the revisions due to the acetabular cup (wear of polyethylene, wrong position) was evaluated at 90% after 10 years and 85,5% after 15 years. The results were better for the ATLAS III coated in hydroxyapatite: 92,3% after 10 years and 88,4% after 14 years, which confirms the advantages of this surface treatment. In this series, the revision rate for wear of the polyethylene was less important (3%). With a maximum of 17 years follow up no mobilisation of the insert in the cup had been observed and no metallosis. Conclusion: The survival rate of the global series of 297 ATLAS (coated and non coated with hydroxyapatite), taking into consideration only the revisions due to the cup (wear of the polyethylene, wrong position) was of 90% after 10 years and 85,5% after 15 years. The rate was higher for the ATLAS III coated with hydroxyapatite: 92,3% after 10 years and 88,4 % after 14 years, which confirmed the advantages of this surface treatment

Aims

Unicompartmental knee arthroplasty (UKA) has a higher risk of revision than total knee arthroplasty (TKA), particularly for younger patients. The outcome of knee arthroplasty is typically defined as implant survival or revision incidence after a defined number of years. This can be difficult for patients to conceptualize. We aimed to calculate the ‘lifetime risk’ of revision for UKA as a more meaningful estimate of risk projection over a patient’s remaining lifetime, and to compare this to TKA.

Aims

The success of total knee arthroplasty (TKA) is usually measured using functional outcome scores and revision-free survivorship. However, reporting the lifetime risk of revision may be more meaningful to patients when gauging risks, especially in younger patients. We aimed to assess the lifetime risk of revision for patients in different age categories at the time of undergoing primary TKA.

Aims

Joint registries typically use revision of an implant as an endpoint and report survival rates after a defined number of years. However, reporting lifetime risk of revision may be more meaningful, especially in younger patients. We aimed to assess lifetime risk of revision for patients in defined age groups at the time of primary surgery.

Aims

The purpose of this retrospective study was to evaluate the minimum five-year outcome of revision total hip arthroplasty (THA) using the Kerboull acetabular reinforcement device (KARD) in patients with Paprosky type III acetabular defects and destruction of the inferior margin of the acetabulum.

We describe 129 consecutive revision total hip replacements using a Charnley-Kerboull femoral component of standard length with impaction allografting. The mean follow-up was 8.2 years (2 to 16). Additionally, extramedullary reinforcement was performed using struts of cortical allograft in 49 hips and cerclage wires in 30.

There was one intra-operative fracture of the femur but none later. Two femoral components subsided by 5 mm and 8 mm respectively, and were considered to be radiological failures. No further revision of a femoral component was required. The rate of survival of the femoral component at nine years, using radiological failure as the endpoint, was 98%. Our study showed that impaction grafting in association with a Charnley-Kerboull femoral component has a low rate of subsidence. Reconstruction of deficiencies of distal bone with struts of cortical allograft appeared to be an efficient way of preventing postoperative femoral fracture for up to 16 years.

We have evaluated the in vivo migration patterns of 164 primary consecutive Charnley-Kerboull total hip replacements which were undertaken in 155 patients. The femoral preparation included removal of diaphyseal cancellous bone to obtain primary rotational stability of the stem before line-to-line cementing. We used the Ein Bild Roentgen Analyse femoral component method to assess the subsidence of the femoral component.

At a mean of 17.3 years (15.1 to 18.3) 73 patients were still alive and had not been revised, eight had been revised, 66 had died and eight had been lost to follow-up. The mean subsidence of the entire series was 0.63 mm (0.0 to 1.94). When using a 1.5 mm threshold, only four stems were considered to have subsided. Our study showed that, in most cases, a highly polished double-tapered stem cemented line-to-line does not subside at least up to 18 years after implantation.

We analysed at a mean follow-up of 7.25 years the clinical and radiological outcome of 117 patients (125 knees) who had undergone a primary, cemented, modular Freeman-Samuelson total knee replacement. While the tibial and femoral components were cemented, the patellar component was uncemented. A surface-cementing technique was used to secure the tibial components. A total of 82 knees was available for radiological assessment. Radiolucent lines were seen in 41 knees (50%) and osteolytic lesions were seen in 13 knees (16%). Asymptomatic, rotational loosening of the patellar implant was seen in four patients and osteolysis was more common in patients with a patellar resurfacing. Functional outcome scores were available for 41 patients (41 knees, 35%) and the mean Western Ontario McMasters Universities score was 77.5 (sd 19.5) and the cumulative survival was 93.4% at ten years with revision for aseptic loosening as an endpoint. Increased polyethylene wear from modular components, a rotationally-loose patella, and the surface-cementing technique may have contributed to the high rate of osteolysis seen in our study.